The Sunday Times’ tech correspondent Danny Fortson brings on David Stein, chief executive of Babson Diagnostics, to talk about the importance of blood testing (4:49), why Babson is not Theranos (6:47), trying to compete with that idea (9:26), why they succeeded where Theranos failed (14:34), using a tiny amount of blood (18:23), fighting against the Theranos effect (24:37), being owned by a company they aim to disrupt (26:28), liquid biopsies (28:02), the new age of biological data (32:23), regulatory approval (37:09), and avoiding the spotlight (39:03). Hosted on Acast. See acast.com/privacy for more information.

Babson’s David Stein: “Succeeding where Theranos failed”

After more than a decade in London, Danny Fortson returns to Silicon Valley to meet the techies trying to change the world - and make loads of money while doing it. Hosted on Acast. See acast.com/privacy for more information.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Would you watch an Olympics where everyone was doping? The Sunday Times’ tech correspondent Danny Fortson brings on Aron D’Souza, co-founder and president of the Enhanced Games, to talk about launching a new competition where everyone is pharmacologically enhanced (6:00), the events (10:00), why he started it (14:50), meeting Peter Thiel (18:20), leading the Gawker case (19:30), the response from the Olympics (23:00), how it could go wrong (26:00), making sure noone dies (28:10), adding robotics and cybernetics (32:20), the funders (35:00), lining up media rights (39:00), the most recent doping scandal (41:00), and the coming legal fight (41:45).  Hosted on Acast. See acast.com/privacy for more information.

Enhanced Games’ Aron D’Souza: “The Olympics are broken”

The Sunday Times’s tech correspondent Danny Fortson brings on Augustus Doricko to talk about becoming a Thiel fellow (3:15), looking for the proof of God (5:45), starting his first company (9:30) cloud seeding (11:30), the history of cloud seeding (13:30), on whether silver iodide is safe (17:00), how it would work in practice (20:30), how it could go wrong (27:30), geo-engineering (30:45), why now (23:15), the Dubai example (35:00), and finding God (38:45).  

 Hosted on Acast. See acast.com/privacy for more information.

Rainmaker's Augustus Doricko: "Cloud seeding is a risk worth taking"

The Sunday Times’ tech correspondent Danny Fortson brings on DoNotPay's Josh Browder to talk about how artificial intelligence is changing his business (4:20), paying a dividend (8:15), blowing up the myth that you have to lose money to get big (11:00), the coming AI crash (13:00), the path forward for DoNotPay (16:40), San Francisco’s moment (19:30), his biggest mistake (21:30), protecting AI’s (24:00), and ambient intelligence (27:40). Hosted on Acast. See acast.com/privacy for more information.

DoNotPay's Josh Browder: "We need laws to protect AI's"

The Sunday  Times’ tech correspondent Danny Fortson brings on Sid Jha of Arbol to talk about the importance of insurance (3:45), using data to change how it works (8:20), how climate has scrambled the industry (10:30), regulation (14:20), creating a new asset class (16:40), weather (24:10), growing up in India (29:20), going to Wall Street (30:40), launching Arbol (33:00), the space revolution (35:40), using blockchain (37:30), and why life is more expensive in an era of climate change (42:45) Hosted on Acast. See acast.com/privacy for more information.

Arbol's Sid Jha: "Insurance in the era of climate calamities"

The Sunday Times correspondent brings on Noor Siddiquui, founder of Orchid, to talk about screening embryos (5:00), starting the company (9:30), hiring people as a first time founder (13:00), targeting ageing at the very beginning (15:00), how it works (18:20), why she thinks this is the future of conception (22:00), the need for regulation (31:00), the potential to exacerbate societal problems (38:00), why longevity enthusiasts invested (40:30), and the potential conservative backlash (49:40).  Hosted on Acast. See acast.com/privacy for more information.

Babson’s David Stein: “Succeeding where Theranos failed”

Download our free app to listen on your phone